Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial
Abroad (travel likely)RecruitingPHASE2
Conditions
Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Early Stage HER2-Positive Breast Carcinoma · Early Stage Triple-Negative Breast Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
M D Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Vicente Valero, MD)
Study leads
Vicente Valero, MD
Principal Investigator
M.D. Anderson Cancer Center